.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Julphar
Johnson and Johnson
Novartis
McKesson
Harvard Business School
US Army
Moodys
Colorcon
AstraZeneca

Generated: September 24, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Which drugs does patent 5,834,448 protect, and when does it expire?


Patent ► Subscribe protects CYANOKIT and is included in one NDA.

This patent has twelve patent family members in nine countries.

Summary for Patent: ► Subscribe

Title: Dosage form of hydroxocobalamin and its use in cyanide poisoning
Abstract:The invention relates to a new dosage form of hydroxocobalamin which serves in the treatment of cyanide poisoning and contains hydroxocobalamin in freeze-dried form. The hydroxocobalamin is freeze-dried in an acidic medium so as to be practically instantly redissolved in a neutral saline solution. The present invention also relates to a process for producing hydroxocobalamin-based pharmaceutical compositions as well as to first aid kits containing these compositions and methods of using such kits for the treatment of cyanide poisoning.
Inventor(s): Pouchol; Gerard (Paris, FR), Bonhomme; Yves (Charbonnieres, FR), Poulain; Marie-Laure (St-Cyr-En-Val, FR), Duran; Michel (St-Cyr-Au-Mont-d'or, FR)
Assignee: Merck Patent Gesellschaft mit beschrankter Haftung (DE)
Application Number:08/748,790
Patent Claim Types:
see list of patent claims
Composition; Formulation; Process; Use; Device;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Serb Sa
CYANOKIT
hydroxocobalamin
INJECTABLE;INJECTION022041-002Dec 15, 2006DISCNNoNo► Subscribe► SubscribeY TREATMENT OF KNOWN OR SUSPECTED CYANIDE POISONING
Serb Sa
CYANOKIT
hydroxocobalamin
INJECTABLE;INJECTION022041-001Apr 8, 2011RXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: ► Subscribe

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France95 13512Nov 15, 1995

International Patent Family for Patent: ► Subscribe

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia7172096► Subscribe
Australia720219► Subscribe
Germany69619767► Subscribe
Denmark0775485► Subscribe
European Patent Office0775485► Subscribe
Spain2171591► Subscribe
France2740973► Subscribe
Iceland1880► Subscribe
Iceland4387► Subscribe
Japan3699223► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Daiichi Sankyo
Queensland Health
Fuji
Moodys
Cipla
US Department of Justice
Citi
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot